Back to search
Hyperuricemia and MAFLD
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperuricemia and MAFLD trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperuricemia and MAFLD trials you may qualify forMASLD is with 25% the most prevalent liver disorder in Western society and is associated with overweight, obesity, metabolic syndrome (MetS), type 2 diabetes me…
Due to the established correlation between serum uric acid (SUA) levels and metabolic associated fatty liver disease (MAFLD), this study aims to screen for hype…
Metabolic associated fatty liver disease (MAFLD) is the most common and harmful chronic liver disease, and it is increasingly diagnosed in many developed and de…